Petersen Mette Bisgaard, Wawegama Nadeeka K, Denwood Matthew, Markham Philip F, Browning Glenn F, Nielsen Liza Rosenbaum
Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Grønnegårdsvej 8, 1870, Frederiksberg, Denmark.
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
BMC Vet Res. 2018 Aug 30;14(1):258. doi: 10.1186/s12917-018-1574-1.
Inexpensive and convenient diagnostic tests for use in clinical work and for the surveillance of infection with Mycoplasma bovis are in demand. The objective of this longitudinal field study was to gain knowledge about the dynamics of antibodies against M. bovis in sera from naturally exposed calves with and without different clinical signs, measured by two different ELISA tests.
A total of 83 calves were subject to between one and five blood samples and clinical examinations using a standard protocol during five herd visits to each of four outbreak dairy herds. The blood samples were analysed for the presence of antibodies against M. bovis using the commercial IgG ELISA test BioX K302 (BioX) and an in-house indirect IgG ELISA test (MilA ELISA). Linear mixed models were used to describe and compare the antibody dynamics as measured by the two tests in relation to the disease status and age of the animals. The BioX ELISA response was below the recommended cut-off (37 ODC%) for the entire study period in many of the calves. The estimated mean ODC% increased slowly but did not reach the recommended individual animal cut-off in three of the four herds. The highest estimated ODC% was not reached until the calf was 110-130 days old. The MilA ELISA response rose above the recommended cut-off (135 antibody units (AU)) in almost all calves, and in two herds, the estimated mean was above the individual animal cut-off shortly after the birth of the calf. The highest estimated antibody concentration was reached when the calf was approximately 60 days old. Disease status of the calf was not significantly associated with the results of either test.
We conclude that the BioX ELISA cannot be recommended for use in calves below 3 months of age. The MilA ELISA was able to detect antibodies shortly after birth (i.e. from approximately 3 weeks of age and onwards) and is therefore a more sensitive test for M. bovis exposure in young calves. Neither ELISA seemed able to differentiate between calves with arthritis and/or otitis media, and respiratory disease.
临床工作及牛支原体感染监测需要价格低廉且使用方便的诊断检测方法。这项纵向现场研究的目的是通过两种不同的酶联免疫吸附测定(ELISA)检测方法,了解自然暴露的有或无不同临床症状的犊牛血清中抗牛支原体抗体的动态变化。
在对四个暴发的奶牛场进行的五次畜群访查期间,共对83头犊牛按照标准方案进行了一至五次血样采集和临床检查。使用商业IgG ELISA检测BioX K302(BioX)和一种内部间接IgG ELISA检测(MilA ELISA)分析血样中抗牛支原体抗体的存在情况。采用线性混合模型来描述和比较两种检测方法所测抗体动态变化与动物疾病状态和年龄的关系。在整个研究期间,许多犊牛的BioX ELISA反应低于推荐的临界值(37光密度变化百分比(ODC%))。四个牛群中有三个牛群的估计平均ODC%增长缓慢,但未达到推荐的个体动物临界值。直到犊牛110 - 130日龄时才达到最高估计ODC%。几乎所有犊牛的MilA ELISA反应都高于推荐的临界值(135抗体单位(AU)),在两个牛群中,估计平均值在犊牛出生后不久就高于个体动物临界值。犊牛约60日龄时达到最高估计抗体浓度。犊牛的疾病状态与任何一种检测结果均无显著关联。
我们得出结论,不建议在3月龄以下的犊牛中使用BioX ELISA。MilA ELISA能够在出生后不久(即大约3周龄及以后)检测到抗体,因此对于幼龄犊牛接触牛支原体而言是一种更灵敏的检测方法。两种ELISA检测方法似乎都无法区分患有关节炎和/或中耳炎以及呼吸道疾病的犊牛。